RecallDepth
Class III Terminated

Risedronate Sodium Delayed-release Tablets, 35 mg, Once-a-Week, 1 tablet per blister (NDC 0093-5509-19), packaged in 4 blisters per carton (NDC 0093-5509-44), Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454.

This recall has been terminated (originally issued March 15, 2017).

Company
Teva Pharmaceuticals Usa
Recall Initiated
February 17, 2017
Posted
March 15, 2017
Recall Number
D-0511-2017
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
25,916 cartons
Firm Location
North Wales, PA, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Dissolution Specifications: low out of specification dissolution results found during stability testing.

Distribution

Nationwide in the United States and Puerto Rico

Lot / Code Info

Lot # 34025762A, Exp 06/17

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class III Drug recalls